文献速递认知障碍与谵妄安宁疗护

认知障碍梯度下转移性癌症养老院患者的激进临终治疗

Aggressive end-of-life care across gradients of cognitive impairment in nursing home patients with metastatic cancer.
PubMed 文献 · J Am Geriatr Soc · 2023-07-29

该研究利用SEER-Medicare-MDS 3.0链接数据,纳入2013—2017年有养老院住院史并死于转移性癌症的患者40,833例,按认知障碍程度分层分析激进临终治疗模式。结果与假设相反,严重认知障碍患者接受任何激进临终治疗的几率比认知完好者高86%(aOR 1.86,95%CI 1.70–2.04),主要与院内死亡几率升高相关,尤其短期住院者(aOR 2.58,95%CI 2.35–2.84)。

要点

  • 严重认知障碍者激进临终治疗几率高于认知完好者(aOR 1.86,95%CI 1.70–2.04)。
  • 严重认知障碍与院内死亡几率升高相关,短期住院者aOR 2.58(2.35–2.84)。
  • 认知完好者激进临终治疗比例为62.6%,严重认知障碍者为74.2%。

核心结论

  • 与假设相反,有养老院住院史的转移性癌症患者中,严重认知障碍者激进临终治疗几率最高。

研究设计与样本

  • 利用SEER-Medicare-MDS 3.0链接数据,识别2013—2017年有养老院住院史并死于转移性癌症的患者共40,833例。
  • 采用描述性分析和多因素logistic回归评估认知障碍严重程度与激进临终治疗之间的独立关联。

主要发现

  • 研究人群认知状态分布:认知完好49.2%,轻度认知障碍24.4%,中度19.7%,重度6.7%。
  • 接受任何激进临终治疗的比例:认知完好者62.6%,严重认知障碍者74.2%。
  • 与认知完好者相比,严重认知障碍者接受任何激进临终治疗的aOR为1.86(95%CI 1.70–2.04)。
  • 严重认知障碍与院内死亡几率升高相关,短期住院者aOR 2.58(95%CI 2.35–2.84),长期住院者aOR 1.40(95%CI 1.17–1.67)。

关键数值与推荐

  • 激进临终治疗标记包括:生命最后30天内接受癌症导向治疗、入住ICU、>1次急诊就诊或>1次住院,生命最后3天内入临终关怀,以及院内死亡。

临床怎么用

  • 提示对养老院严重认知障碍的转移性癌症患者需关注激进临终治疗风险,可据此开发干预措施以减少该人群的激进临终治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies examining end-of-life (EOL) care in older cancer patients are scarce, and prior studies have not accounted for gradients of cognitive impairment (COG-I). We examine EOL care patterns across COG-I gradients, hypothesizing that greater COG-I severity is associated with lower odds of receiving aggressive EOL care. METHODS: Using data from the linked Surveillance Epidemiology and End Results (SEER) -Medicare -Minimum Data Set (MDS) 3.0, we identified patients with nursing facility stays (NFS) and who died with metastatic cancer from 2013 to 2017. Markers of aggressive EOL care were: cancer-directed treatment, intensive care unit admission, >1 emergency department visit, or >1 hospitalization in the last 30 days of life, hospice enrollment in the last 3 days of life, and in-hospital death. In addition to descriptive analysis, we conducted multivariable logistic regression analysis to evaluate the independent association between COG-I severity and receipt of aggressive EOL care. RESULTS: Of the 40,833 patients in our study population, 49.2% were cognitively intact; 24.4% had mild COG-I; 19.7% had moderate COG-I; and 6.7% had severe COG-I. The percent of patients who received aggressive EOL care was 62.6% and 74.2% among those who were cognitively intact and those with severe COG-I, respectively. Compared with cognitively intact patients, those with severe COG-I had 86% higher odds of receiving any type of aggressive EOL care (adjusted odds ratio (aOR): 1.86 (95% confidence interval: 1.70-2.04)), which were primarily associated with higher odds of in-hospital death. The odds of in-hospital death associated with severe COG-I were higher among those with short- than with long-term stays (aOR:2.58 (2.35-2.84) and aOR:1.40 (1.17-1.67), respectively). CONCLUSIONS: Contrary to our hypothesis, aggressive EOL care in older metastatic cancer patients with NFS was highest among those suffering severe COG-I. These findings can inform the development of interventions to help reduce aggressive EOL care in this patient population.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Koroukian SM, Douglas SL, Vu L, et al. Aggressive end-of-life care across gradients of cognitive impairment in nursing home patients with metastatic cancer. J Am Geriatr Soc. 2023. PMID: 37515440. doi:10.1111/jgs.18526

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。